Clinically Apparent Atrial Fibrillation Increases Stroke Risk; Does Subclinical AFib Do the Same?

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Stuart J. Connelly, MD, one of the principal authors of “Subclinical Atrial Fibrillation and the Risk of Stroke,” published in the New England Journal of Medicine, talks about the study.  

To listen to the podcast, click here.
Related Articles
Non-vitamin K antagonist oral anticoagulants are increasingly being prescribed to prevent and treat venous thromboembolism and avert stroke in patients with atrial fibrillation.
Is there a need to strengthen the labeling of topical NSAIDs that clearly lack systemic therapeutic or toxic levels?
Six patient deaths and other serious adverse events have been linked to SentreHeart’s Lariat Suture Delivery Device, the FDA is warning health care professionals.
Here are new drugs for 2015 that pharmacists can expect to handle.
Latest Issues
$auto_registration$